PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
AVID vs. OLMA
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


AVIDOLMA

Fundamentals


AVIDOLMA
Market Cap$1.19B$596.81M
EPS$0.72-$2.14
Revenue (TTM)$413.46M$0.00
Gross Profit (TTM)$274.44M$0.00
EBITDA (TTM)$28.62M-$104.58M

Correlation

-0.50.00.51.00.2

The correlation between AVID and OLMA is 0.17, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

AVID vs. OLMA - Performance Comparison

The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-50.00%0.00%50.00%100.00%December2024FebruaryMarchAprilMay
121.28%
-77.06%
AVID
OLMA

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Avid Technology, Inc.

Olema Pharmaceuticals, Inc.

Risk-Adjusted Performance

AVID vs. OLMA - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Avid Technology, Inc. (AVID) and Olema Pharmaceuticals, Inc. (OLMA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


AVID
Sharpe ratio
The chart of Sharpe ratio for AVID, currently valued at 0.68, compared to the broader market-2.00-1.000.001.002.003.000.68
Sortino ratio
The chart of Sortino ratio for AVID, currently valued at 2.13, compared to the broader market-4.00-2.000.002.004.006.002.13
Omega ratio
The chart of Omega ratio for AVID, currently valued at 1.45, compared to the broader market0.501.001.502.001.45
Calmar ratio
The chart of Calmar ratio for AVID, currently valued at 0.45, compared to the broader market0.002.004.006.000.45
Martin ratio
The chart of Martin ratio for AVID, currently valued at 4.27, compared to the broader market-10.000.0010.0020.0030.004.27
OLMA
Sharpe ratio
The chart of Sharpe ratio for OLMA, currently valued at 0.80, compared to the broader market-2.00-1.000.001.002.003.000.80
Sortino ratio
The chart of Sortino ratio for OLMA, currently valued at 1.61, compared to the broader market-4.00-2.000.002.004.006.001.61
Omega ratio
The chart of Omega ratio for OLMA, currently valued at 1.19, compared to the broader market0.501.001.502.001.19
Calmar ratio
The chart of Calmar ratio for OLMA, currently valued at 0.76, compared to the broader market0.002.004.006.000.76
Martin ratio
The chart of Martin ratio for OLMA, currently valued at 3.27, compared to the broader market-10.000.0010.0020.0030.003.27

AVID vs. OLMA - Sharpe Ratio Comparison


Rolling 12-month Sharpe Ratio-1.000.001.002.003.004.005.006.00December2024FebruaryMarchAprilMay
0.68
0.80
AVID
OLMA

Dividends

AVID vs. OLMA - Dividend Comparison

Neither AVID nor OLMA has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

AVID vs. OLMA - Drawdown Comparison


-80.00%-70.00%-60.00%-50.00%-40.00%-30.00%December2024FebruaryMarchAprilMay
-32.21%
-79.38%
AVID
OLMA

Volatility

AVID vs. OLMA - Volatility Comparison

The current volatility for Avid Technology, Inc. (AVID) is 0.00%, while Olema Pharmaceuticals, Inc. (OLMA) has a volatility of 16.09%. This indicates that AVID experiences smaller price fluctuations and is considered to be less risky than OLMA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%25.00%30.00%35.00%December2024FebruaryMarchAprilMay0
16.09%
AVID
OLMA

Financials

AVID vs. OLMA - Financials Comparison

This section allows you to compare key financial metrics between Avid Technology, Inc. and Olema Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items